By Marcus A. Banks
Glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors should be temporarily withheld prior to elective surgery to avoid complications, according to a presentation at the Critical Care Congress 2025, in Orlando, Fla.
Data routinely collected in the electronic health record (EHR) can guide these decisions, said Laura Ebbitt, PharmD, BCCP, a surgical acute care pharmacist at the University of Kentucky (UK) Chandler Medical Center, in